Patents by Inventor Rajeev Singh

Rajeev Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180008619
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: September 22, 2017
    Publication date: January 11, 2018
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • Publication number: 20170340561
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Inventors: Sagar MUNJAL, Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • Publication number: 20170340594
    Abstract: The present application relates to pharmaceutical compositions comprising retinoic acid or its derivatives such as isotretinoin and processes for preparing thereof. It also provides methods for treating acne by administering such pharmaceutical composition to a patient in need thereof.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Inventors: Yogesh Bapurao PAWAR, Kailas KHOMANE, Saurabh SRIVASTAVA, Bijay Kumar PADHI, Rajeev Singh RAGHUVANSHI
  • Patent number: 9795620
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: October 24, 2017
    Assignee: Dr. Reddy's Laboratories, Ltd.
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • Publication number: 20170273918
    Abstract: The present application relates to a method of treating Parkinson's disease by administering a mouth-dissolving composition of N-propargylamine derivative, such as rasagiline or a pharmaceutically-acceptable salt thereof.
    Type: Application
    Filed: March 27, 2017
    Publication date: September 28, 2017
    Inventors: Chandrakant Bamtu VELIP, Anup Avijit CHOUDHURY, Girish KARANTH, Rajeev Singh RAGHUVANSHI
  • Publication number: 20170119798
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: December 9, 2016
    Publication date: May 4, 2017
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • Publication number: 20170119738
    Abstract: The present application relates to a method of treating a migraine headache in a patient by administering a pharmaceutical composition including rizatriptan or pharmaceutically acceptable salts thereof contained in a unit dose.
    Type: Application
    Filed: October 28, 2016
    Publication date: May 4, 2017
    Inventors: Rajeev Singh RAGHUVANSHI, Piyush GUPTA, Rajesh Ramesh PATIL, Mohan RATHI
  • Publication number: 20170071957
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Application
    Filed: November 22, 2016
    Publication date: March 16, 2017
    Applicant: Dr. Reddy's Laboratories Ltd.
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi
  • Publication number: 20170071930
    Abstract: The present application discloses a pharmaceutical composition comprising a class of CETP inhibitors with improved oral bioavailability. The application further discloses compositions comprising a class of CETP inhibitor and at least one solubility improving material and optionally one or more wetting agents.
    Type: Application
    Filed: November 19, 2013
    Publication date: March 16, 2017
    Inventors: Bijay Kumar Padhi, Rajesh Gandhi, Swati Arun Guhagarkar, Rajeev Singh Raghuvanshi
  • Patent number: 9572819
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: February 21, 2017
    Assignee: Dr. Reddy's Laboratories, Ltd.
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • Publication number: 20170035729
    Abstract: The present application relates to a method of treating migraine or cluster headache in a human patient, said method comprising administering subcutaneously composition comprising sumatriptan or its pharmaceutically acceptable salt, in an amount equivalent to 3 mg sumatriptan base.
    Type: Application
    Filed: January 29, 2016
    Publication date: February 9, 2017
    Inventors: Prabhu Prabhakara, Rajesh Ramesh Patil, Piyush Gupta, Rajeev Singh Raghuvanshi, Anil N. Namboodiripad
  • Patent number: 9532996
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: January 3, 2017
    Assignee: Dr. Reddy's Laboratories Ltd.
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi
  • Publication number: 20160346301
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: May 27, 2016
    Publication date: December 1, 2016
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • Publication number: 20160296537
    Abstract: The present application relates to a method of orally administering once daily tablet of minocycline to a subject in need thereof, wherein said tablet is substantially free of lactose. The present application also relates to processes for preparing said once daily tablet of minocycline that provides reduced stock keeping units with improved inventory by supplying multiple doses of minocycline in single tablet.
    Type: Application
    Filed: April 7, 2016
    Publication date: October 13, 2016
    Inventors: Rohit LOWALEKAR, Bijay Kumar PADHI, Rajeev Singh RAGHUVANSHI
  • Publication number: 20160294706
    Abstract: A single cellular radio is enabled to support multiple phone lines and data service. The system can be split into two parts: a telephone adapter that receives input from one or more phone lines, and a wireless hot spot communicably coupled to one or more telephone adapters that transmits communications associated with the phone lines and data service to the mobile network. The telephone adapter can include phone jacks, WiFi, and LAN connections and also some traffic management functionality that routes voice traffic to higher class of services than non-voice data. The wireless hotspot can then map communications with higher classes of service to dedicated bearers with guaranteed bitrates, and the lower classes of service to dedicated bearers with non-guaranteed bitrates or even default bearers.
    Type: Application
    Filed: April 1, 2015
    Publication date: October 6, 2016
    Inventors: Howard Lawrence Lang, Steven Rocconi, James Compton, Rajeev Singh, Vimal Patel
  • Publication number: 20160136187
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Application
    Filed: November 19, 2015
    Publication date: May 19, 2016
    Applicant: Dr. Reddy's Laboratories Ltd.
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi
  • Publication number: 20160000799
    Abstract: The present application discloses a pharmaceutical composition comprising a class of cholesteryl ester transfer protein (CETP) inhibitors with improved oral bioavailability. The application further discloses compositions comprising a class of CETP inhibitor and at least one surfactant in the form of a solution, suspension, emulsion or a pre-concentrate.
    Type: Application
    Filed: February 21, 2014
    Publication date: January 7, 2016
    Inventors: Vijay Kumar Nekkanti, Shantanu Yeshwant Damle, Bijay Kumar Padhi, Rajesh Gandhi, Rajeev Singh Raghuvanshi
  • Publication number: 20130259947
    Abstract: The present invention relates to an oral pharmaceutical composition comprising metronidazole, wherein metronidazole is released from the composition generally at the pH 5.0 and above.
    Type: Application
    Filed: November 29, 2011
    Publication date: October 3, 2013
    Applicant: DR. REDDY'S LABORATORIES LTD.
    Inventors: Bijay Kumar Padhi, Muzammil Tariq, Sagar Dilip Mandawgade, Rajesh Gandhi, Rajeev Singh Raghuvanshi, Dushyanth Surakanti, Kent Allenby
  • Publication number: 20110034489
    Abstract: The present invention relates to a solid dosage form comprising a solid dispersion composition of at least one HIV protease inhibitor and water soluble polymer having a glass transition temperature (Tg) of at least about 50° C. in an amount of less than 50% by weight of the dosage form. It also relates to a process of preparation of such solid dosage forms.
    Type: Application
    Filed: August 2, 2010
    Publication date: February 10, 2011
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Ravindra TIWARI, Kannayiram K. JANAKIRAMAN, Ravindra AGARWAL, Rajeev Singh RAGHUVANSHI
  • Publication number: 20090264408
    Abstract: The present invention relates to an extended release dosage form of quetiapine wherein the dosage form comprises quetiapine and rate-controlling polymer selected from polyethylene oxide, sodium alginate and natural gum and combinations thereof. The dosage form may additionally comprise at least one water-insoluble polymer.
    Type: Application
    Filed: April 8, 2009
    Publication date: October 22, 2009
    Inventors: Inder Gulati, Rajan Kumar Verma, Rajeev Singh Raghuvanshi, Romi Barat Singh, Kumaravel Vivek, Sweta Varshney